BPC-157 BPC-157 was not prohibited prior to 2022, but the clinically unapproved experimental peptide was added to the 2022 WADA Prohibited List under the S0 Unapproved Substances category
The 4 mm needle is long enough to traverse the skin and reach the subcutaneous tissue with minimal risk of intramuscular or intradermal penetration
Why Willnix How We Compare We believe you deserve to know exactly what you're choosing
Reporting Adverse Events or Safety Concerns If you experience or suspect an adverse event, contamination, or quality issue with this product, report it immediately to: Hospira Pfizer: Manufacturer contact information available on the product vial FDA MedWatch: 1-888-SAFEMED (1-888-723-3633) or online at fda.gov/medwatch Poison Control: 1-800-222-1222 (for toxicology guidance) Your institutional pharmacovigilance system: If you work for a hospital, clinic, or healthcare institution Regulatory Compliance By purchasing and using this product, you agree to comply with all applicable FDA regulations, state pharmacy laws, and professional licensing requirements
Injections of B12 may be given to patients who are unable to absorb this vitamin in their bodies due to problems such as gastrointestinal pathology or dysfunction